Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-052465

EVP, R&D & Chief Scientific Of sold 13,500 shares at $43.08 ($581,580)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Haqq Christopher EVP, R&D & Chief Scientific Of 2018-09-26 Sale −13,500 $43.08 $581,580 286,355 D
Open-market sales · 13,500 sh · avg $43.08 · $581,580
Loading xslF345X03/doc4.xml…